These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 11266465

  • 1. Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.
    Webb DJ, Thomas KS, Gonias SL.
    J Cell Biol; 2001 Feb 19; 152(4):741-52. PubMed ID: 11266465
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro.
    Webb DJ, Nguyen DH, Sankovic M, Gonias SL.
    J Biol Chem; 1999 Mar 12; 274(11):7412-20. PubMed ID: 10066806
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner.
    Nguyen DH, Catling AD, Webb DJ, Sankovic M, Walker LA, Somlyo AV, Weber MJ, Gonias SL.
    J Cell Biol; 1999 Jul 12; 146(1):149-64. PubMed ID: 10402467
    [Abstract] [Full Text] [Related]

  • 6. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility.
    Nguyen DH, Hussaini IM, Gonias SL.
    J Biol Chem; 1998 Apr 03; 273(14):8502-7. PubMed ID: 9525964
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
    Nykjaer A, Kjøller L, Cohen RL, Lawrence DA, Garni-Wagner BA, Todd RF, van Zonneveld AJ, Gliemann J, Andreasen PA.
    J Biol Chem; 1994 Oct 14; 269(41):25668-76. PubMed ID: 7929271
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading.
    Planus E, Barlovatz-Meimon G, Rogers RA, Bonavaud S, Ingber DE, Wang N.
    J Cell Sci; 1997 May 14; 110 ( Pt 9)():1091-8. PubMed ID: 9175705
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
    Bryan L, Paugh BS, Kapitonov D, Wilczynska KM, Alvarez SM, Singh SK, Milstien S, Spiegel S, Kordula T.
    Mol Cancer Res; 2008 Sep 14; 6(9):1469-77. PubMed ID: 18819934
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion.
    Bonavaud S, Charrière-Bertrand C, Rey C, Leibovitch MP, Pedersen N, Frisdal E, Planus E, Blasi F, Gherardi R, Barlovatz-Meimon G.
    J Cell Sci; 1997 May 14; 110 ( Pt 9)():1083-9. PubMed ID: 9175704
    [Abstract] [Full Text] [Related]

  • 15. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator.
    Jo M, Thomas KS, Marozkina N, Amin TJ, Silva CM, Parsons SJ, Gonias SL.
    J Biol Chem; 2005 Apr 29; 280(17):17449-57. PubMed ID: 15728176
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
    Kobayashi H, Suzuki M, Kanayama N, Nishida T, Takigawa M, Terao T.
    Int J Cancer; 2002 Dec 01; 102(4):379-89. PubMed ID: 12402308
    [Abstract] [Full Text] [Related]

  • 18. TFPI or uPA-PAI-1 complex affect cell function through expression variation of type II very low density lipoprotein receptor.
    Di Y, Liu Z, Tian J, Zong Y, Yang P, Qu S.
    FEBS Lett; 2010 Aug 04; 584(15):3469-73. PubMed ID: 20624392
    [Abstract] [Full Text] [Related]

  • 19. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells.
    Tang H, Kerins DM, Hao Q, Inagami T, Vaughan DE.
    J Biol Chem; 1998 Jul 17; 273(29):18268-72. PubMed ID: 9660790
    [Abstract] [Full Text] [Related]

  • 20. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events.
    Schlaepfer DD, Jones KC, Hunter T.
    Mol Cell Biol; 1998 May 17; 18(5):2571-85. PubMed ID: 9566877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.